Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6529
    +0.0029 (+0.45%)
     
  • OIL

    82.80
    -0.01 (-0.01%)
     
  • GOLD

    2,338.20
    -0.20 (-0.01%)
     
  • Bitcoin AUD

    97,202.33
    -4,464.39 (-4.39%)
     
  • CMC Crypto 200

    1,356.93
    -25.65 (-1.86%)
     
  • AUD/EUR

    0.6084
    +0.0014 (+0.23%)
     
  • AUD/NZD

    1.0954
    +0.0013 (+0.11%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,088.36
    +47.98 (+0.60%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,969.17
    -119.53 (-0.66%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Trade Alert: The Chairman Of Global Medical REIT Inc. (NYSE:GMRE), Jeffrey Busch, Has Just Spent US$134k Buying 35% More Shares

Investors who take an interest in Global Medical REIT Inc. (NYSE:GMRE) should definitely note that the Chairman, Jeffrey Busch, recently paid US$13.39 per share to buy US$134k worth of the stock. That's a very solid buy in our book, and increased their holding by a noteworthy 35%.

See our latest analysis for Global Medical REIT

Global Medical REIT Insider Transactions Over The Last Year

Notably, that recent purchase by Jeffrey Busch is the biggest insider purchase of Global Medical REIT shares that we've seen in the last year. That means that an insider was happy to buy shares at around the current price of US$13.41. Of course they may have changed their mind. But this suggests they are optimistic. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. Happily, the Global Medical REIT insiders decided to buy shares at close to current prices.

ADVERTISEMENT

While Global Medical REIT insiders bought shares during the last year, they didn't sell. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
insider-trading-volume

Global Medical REIT is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Does Global Medical REIT Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that Global Medical REIT insiders own 3.1% of the company, worth about US$20m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The Global Medical REIT Insider Transactions Indicate?

It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. Insiders likely see value in Global Medical REIT shares, given these transactions (along with notable insider ownership of the company). In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Global Medical REIT. Be aware that Global Medical REIT is showing 5 warning signs in our investment analysis, and 1 of those is significant...

Of course Global Medical REIT may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.